Avansdose Pantoprazole Pellets, CAS No. : 102625-70-7

Listing ID #2697315

Get Latest Price

TypeEntric Coated Pellets
Brand NameAvansdose
CAS No.102625-70-7
Other NamesSomac, Pantoloc, Protium, Pantecta, Protonix, and Pantoheal
Supply Type Exporter, Supplier
Preferred Buyer Location All over the world

View More Details

Product Details

Avanscure Lifesciences Pvt. Ltd., global Manufacturer of Pantoprazole pellets offers for your requirements of RND / Development quantities or commercials, based on status of the product.

Pantoprazole (sold under various brand names including Somac, Pantoloc, Protium, Pantecta, Protonix, and Pantoheal) is a proton pump inhibitor drug that inhibits gastric acid secretion.
Available Form:
Pantoprazole Sodium EC Pellets
Pantoprazole Sodium EC Pellets + Domperidone SR Pellets
Pantoprazole Sodium Granules

Pantoprazole Sodium Pellets
Systematic (IUPAC) Name

Pantoprazole Sodium Pellets
Identifiers

Pantoprazole Sodium Pellets
Chemical data

(RS)-6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzo[d]imidazole

CAS number : 102625-70-7

Formula: C16H15F2N3O4S

Mol. mass: 383.371 g/mol

Additional Information

Packaging Details As per buyer requirements

Company Details

AvansCure was established to provide global sourcing and international marketing expertise services to pharmaceutical, biotech and medical devices companies in the area of Active Pharmaceutical Ingredients (APIs), formulations, biological products, chemicals and intermediates. Over the recent years we have established excellent relationships with a mix of companies specializing both in the research and manufacture of ingredients for pharmaceutical applications. Our clients benefit from these existing relationships by getting quick and professional response from our suppliers. We work hard on behalf of our clients in the area of quality and responsiveness but also for competitive pricing and timeliness of deliveries.
Our strength is our size, being a small organization we can act quickly either offering sources from our network of suppliers or seeking out alternatives or new sources. We have been able to respond with samples of raw materials within days of receiving a brief from clients. Good communication and clarity on with whom and where our potential sources are the bedrock of our relationships with our clients. Present clients are a mix of large multinational and newer companies manufacturing product for market or designing new drugs and delivery systems.